Revive Therapeutics Ltd. (CSE:RVV)
 0.0150
 +0.0050 (50.00%)
  Oct 31, 2025, 10:55 AM EDT
Revive Therapeutics Statistics
Total Valuation
CSE:RVV has a market cap or net worth of CAD 6.60 million. The enterprise value is 6.65 million.
| Market Cap | 6.60M | 
| Enterprise Value | 6.65M | 
Important Dates
The last earnings date was Wednesday, October 29, 2025.
| Earnings Date | Oct 29, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
CSE:RVV has 440.03 million shares outstanding. The number of shares has increased by 10.31% in one year.
| Current Share Class | 440.03M | 
| Shares Outstanding | 440.03M | 
| Shares Change (YoY) | +10.31% | 
| Shares Change (QoQ) | +1.10% | 
| Owned by Insiders (%) | 1.44% | 
| Owned by Institutions (%) | 0.00% | 
| Float | 433.70M | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| PB Ratio | -1.91 | 
| P/TBV Ratio | n/a | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | -0.60 | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 | 
| Quick Ratio | 0.00 | 
| Debt / Equity | n/a | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | -2,613.63 | 
Financial Efficiency
Return on equity (ROE) is -583.18% and return on invested capital (ROIC) is -53.38%.
| Return on Equity (ROE) | -583.18% | 
| Return on Assets (ROA) | -19.05% | 
| Return on Invested Capital (ROIC) | -53.38% | 
| Return on Capital Employed (ROCE) | 49.92% | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | -5.51M | 
| Employee Count | 2 | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
| Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
| Beta (5Y) | 0.49 | 
| 52-Week Price Change | n/a | 
| 50-Day Moving Average | 0.02 | 
| 200-Day Moving Average | 0.02 | 
| Relative Strength Index (RSI) | 42.79 | 
| Average Volume (20 Days) | 173,648 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | n/a | 
Income Statement
| Revenue | n/a | 
| Gross Profit | n/a | 
| Operating Income | -1.65M | 
| Pretax Income | -11.01M | 
| Net Income | -11.01M | 
| EBITDA | -1.65M | 
| EBIT | -1.65M | 
| Earnings Per Share (EPS) | -0.03 | 
Balance Sheet
The company has 14,560 in cash and 66,866 in debt, giving a net cash position of -52,306 or -0.00 per share.
| Cash & Cash Equivalents | 14,560 | 
| Total Debt | 66,866 | 
| Net Cash | -52,306 | 
| Net Cash Per Share | -0.00 | 
| Equity (Book Value) | -3.46M | 
| Book Value Per Share | -0.01 | 
| Working Capital | -3.45M | 
Cash Flow
| Operating Cash Flow | -767,658 | 
| Capital Expenditures | n/a | 
| Free Cash Flow | n/a | 
| FCF Per Share | n/a | 
Margins
| Gross Margin | n/a | 
| Operating Margin | n/a | 
| Pretax Margin | n/a | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
CSE:RVV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -10.31% | 
| Shareholder Yield | n/a | 
| Earnings Yield | -166.83% | 
| FCF Yield | n/a | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
| Altman Z-Score | n/a | 
| Piotroski F-Score | 1 |